Floatz logo

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE

Analgesia

Ataturk UniversitySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Analgesia cohort.

Asset / SponsorPhaseRating
NEPENTHE
Meri Mirceta
Phase 4BBB
LIDOCAINE
Meri Mirceta
Phase 4BB
DEXAMETHASONE
Meri Mirceta
Phase 4BB
ROPIVACAINE
Dr Kassiani Theodoraki
Phase 4BB
Vts-K
Theresa Jacob, PhD, MPH
Phase 4BB

View all 28 →

Same molecule, other indications

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:

Pain, PostoperativeDormant
BBB
Indicative ·
78 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
76 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →